During the past 20 years, the prevalence of Down syndrome (DS) has increased with the increase in mean maternal age. The prevalence of multiple births has also increased because of older maternal age and use of assisted reproductive technologies. This study was designed to determine the maternal age–specific prevalence of DS in monozygotic and dizygotic pregnancies, assess risk relative to singleton pregnancies, as well as compare prenatal diagnosis and pregnancy outcomes for DS fetuses in multiple and singleton pregnancies. The database of the European Surveillance of Congenital Anomalies includes live-born congenital anomaly cases, stillborn cases and fetal deaths after 20 weeks’ gestation, as well as prenatally diagnosed cases resulting in termination of pregnancy for fetal anomaly. The study population consisted of 14,827,105 pregnancies between 1990 and 2009, of which 2.89% were multiple gestations. Individual fetuses/babies with DS from multiple and singleton pregnancies were considered “cases.” Twin pairs with both twins having DS were “concordant” pairs. Relative risk (RR) with the 95% confidence interval (CI) was used to estimate the prevalence of cases with DS among multiple births relative to that among singleton births. From 1990 to 1999, the total corrected prevalence of DS cases from multiple pregnancies as opposed to singleton pregnancies per 10,000 births was 0.40 (95% CI, 0.36–0.45), rising to 0.47 (95% CI, 0.42–0.53) in 2000 to 2009 (P > 0.05). Overall (1990–2009), the prevalence of DS cases per 10,000 multiple births was 15.1 (95% CI, 14.6–15.9); and per 10,000 singleton births, 20.1 (95% CI, 19.9–20.3). The prevalence of DS cases per 10,000 multiple births rose with age of 44 years or younger, after which it was considerably lower. The adjusted RR of DS for babies from multiple births relative to singleton births was 0.58 (95% CI, 0.53–0.62). Of 19,397 babies born to mothers older than 44 years, 2043 (10.5%) were from multiple births. Only 1 fetus from a multiple pregnancy was a DS case, a prevalence of 4.48 (95% CI, 0.67–35.1) per 10,000 multiple births, compared with 562 singleton DS cases, a prevalence of 327 (95% CI, 301–356) per 10,000 singleton births (RR, 0.015; 95% CI, 0.002–0.107). In 8.7% (n = 54) of affected pairs, the twins were concordant for DS, 51 same-sex twin pairs and 3 unlike-sex twin pairs. The maternal age–adjusted RR of a monozygotic pregnancy being affected was 0.34 (95% CI, 0.25–0.44) compared with singleton pregnancies. No affected monozygotic twin pregnancies occurred in the group older than 44 years. For dizygotic pregnancies, the maternal age–adjusted RR of at least 1 twin being affected was 1.34 (95% CI, 1.23–1.46) compared with singleton pregnancies. For age older than 44 years, the RR was 0.04 (95% CI, 0.01–0.27). The proportion of DS cases prenatally diagnosed was lower for multiple than for singleton pregnancies at all maternal ages, for an overall maternal age–adjusted odds ratio (OR) of 0.62 (95% CI, 0.50–0.78). The overall proportion of termination of pregnancy for fetal anomaly cases from multiple pregnancies was lower than singletons at every maternal age, giving an overall maternal age–adjusted OR of 0.52 (95% CI, 0.41–0.65). Down syndrome cases from multiple births were not more likely to be stillbirths/fetal deaths than from singleton births; the maternal age–adjusted OR was 1.03 (95% CI, 0.59–1.78). Individual fetuses from twin pregnancies are at lower risk for DS than those from singleton pregnancies. The estimates of the lower maternal age–specific DS risk in twin pregnancies, combined with the clinician’s knowledge of zygosity/chorionicity and maternal age at ovulation for women having assisted reproductive technologies, should allow more accurate risk estimates for genetic counseling and prenatal screening.
Read full abstract